NewsRoom Articles - Page 210 of 252

ThursdayFeb 08, 2018 9:00 am

Opportunity Amid Cannabis Banking Hurdles

CBDWire Editorial Coverage: Investors seeking opportunities in the cannabis market may want to turn their attention toward companies offering solutions for a situation that could otherwise slow the industry’s growth. A number of emerging firms are providing or pursuing payment options that can help cannabis companies sidestep the roadblock created by the lack of access to traditional banking services. Among the companies honing financing, payment processing and other business development services for the cannabis industry are Global Payout, Inc (OTC: GOHE) (GOHE Profile), MassRoots Retail (OTC: MSRT), iAnthus Capital Holdings, Inc. (CSE: IAN) (OTC: ITHUF), and Glance Technologies, Inc. (OTC:…

WednesdayFeb 07, 2018 2:02 pm

Earth Science Tech, Inc. (ETST) Eyes Uplisting to OTCQB, Retains Counsel for Planned Regulation A+ Tier 2 Financing

Goal is to raise $4 million to help company finance its planned projects Expansion into Canada eyed, attorney retained to help seek Canadian licenses to import ETST’s CBD-rich hemp oil into country ETST would also use funding for MSN-2, its home kit for the detection of sexually transmitted diseases Earth Science Tech, Inc. (OTC: ETST) is working toward an uplisting to the OTCQB Venture Market in early 2018. It has also retained counsel for a planned Regulation A+ Tier 2 round of financing, which the company hopes will raise an aggregate of $4 million (http://cnw.fm/W8I2d). The funds would be used…

TuesdayFeb 06, 2018 3:29 pm

EVIO, Inc. (EVIO) is Exceeding Expectations

Investor interest nearly doubles size of placement Company's 2017 revenues soared 438 percent year-over-year On pace to double number of testing facilities this year The regulatory uncertainties surrounding cannabis will have little impact on the long-term growth of the industry. There’s overwhelming scientific evidence validating the medical efficacy of certain cannabinoids and, like all medications, cannabinoids require quality control assurances for potency and purity. Also, much like prohibition, it’s realistic to expect parochial federal regulators to ultimately succumb to the will of the majority and relax any uncertainties around recreational cannabis use. Again, the end product must be tested and…

TuesdayFeb 06, 2018 1:35 pm

Recent Report on PotNetwork Holding Inc. (POTN) Share Price Target Highlights Encouraging Data

Heightened share price target for PotNetwork Holding Inc. set at $1.25 Previous market estimates, exceeded by over 70 percent, show positive month-to-month sales for PotNetwork Holdings Inc. SeeThruEquity report highlights the greatly lowered legal and physiological risk from hemp-derived CBD A recent comprehensive report by SeeThruEquity highlighting PotNetwork Holding Inc. (OTC: POTN) and its subsidiary, Diamond CBD, projected a heightened share price target set at $1.25. The increase was attributed to the company’s strong monthly sales data and 3Q17 filings (http://cnw.fm/A2krk). Per the report, these indicated “continued profitability as the company invests in growth.” In a prior news release, Dr.…

TuesdayFeb 06, 2018 12:30 pm

Teewinot Life Sciences’ Patented Biosynthetic Tech Cuts Costs and Produces Clinical-Grade Cannabinoids

Company’s IP portfolio, including proprietary technology and biosynthetic methods, features seven U.S. patents and patent filings in numerous other key countries around the world Eliminating the high costs of cultivating plants, Teewinot Life Sciences Corporation delivers pure, consistent pharmaceutical-grade cannabinoids Company’s goal is to cut costs and approach cannabinoid production like a pharmaceutical company, not as a cannabis firm Teewinot Life Sciences Corporation has an advantage in consistently producing pure, clinical-grade cannabinoids with its patented biosynthetic technology. The results eliminate the watering and electrical costs of traditional plant cultivation, as well as the variances in quality. Instead, its method offers…

MondayFeb 05, 2018 2:32 pm

ChineseInvestors.com, Inc. (CIIX) Offering Innovative Access to Cryptocurrency

Despite China’s ban on cryptocurrency, CIIX is positioned to lead the way in cryptocurrency education and awareness for the Chinese-speaking community Demand for bitcoin continues to rise despite China’s ban on cryptocurrency Company is committed to the education and growth of cryptocurrency and providing innovative ways of making bitcoin more accessible ChineseInvestors.com, Inc. (OTCQB: CIIX) is continuing its commitment to cryptocurrency education and awareness for the Chinese-speaking community. Its educational services seek to answer the average person’s curiosity while simultaneously providing skilled investors with up-to-date news on digital currency. Using the Chinese language character sets, CIIX provides analysis and education…

MondayFeb 05, 2018 1:49 pm

Skinvisible, Inc. (SKVI), Quoin Pharmaceuticals Proposed Merger to Address Opioid Pain Management Market

A merger between Skinvisible and Quoin will enable a successful entry on the post-surgical pain management market Opioids – which typically refer to oxycodone, hydrocodone, and fentanyl – are highly addictive painkillers; nearly three in 10 Americans prescribed opioids for chronic pain will abuse them Opioids are becoming increasingly deadly to Americans; in 2016, two-thirds of drug-related deaths involved opioids; in fact, since 1999, opioid-related deaths in the United States have increased nearly fourfold Drug abuse is a burden shared by every state; nearly 63,600 Americans lost their lives to drug overdoses in 2016 – a 21 percent increase over…

MondayFeb 05, 2018 12:02 pm

Regulation and Oversight of Virtual Currencies by SEC and CFTC Agencies to be Reviewed, Congressional Hearing Set

The Committee on Banking, Housing and Urban Affairs sets hearing for February 6 to review oversight role of the SEC and CFTC over virtual currencies, such as bitcoin In an op-ed written jointly by the SEC and CFTC, agency chiefs say they would support policy efforts to revisit framework of their cryptocurrency regulation; both will testify before the committee Agencies say they will seek to maintain integrity and transparency in the volatile cryptocurrency markets; goal is to protect all market participants and investors Virtual currency oversight by the Securities and Exchange Commission (SEC) and the U.S. Commodity Futures Trading Commission…

FridayFeb 02, 2018 2:37 pm

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is “One to Watch”

U.S. hemp retail market estimated at $1.8 billion by 2020 with 22% CAGR Global hemp-based cannabidiol (CBD) segment projected to reach $3 billion by 2021 Disruptive potential for industrial hemp products offers substantial rewards Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF), headquartered in British Columbia, Canada, is a publicly traded company founded in 2014. Global Hemp Group is focused on acquiring and developing a strategic portfolio of like-minded companies that believe in the significant potential of the industrial hemp plant. Global Hemp Group’s focused on attracting joint venture partners across all sectors of the industrial hemp industries…

FridayFeb 02, 2018 1:10 pm

Riot Blockchain, Inc. (NASDAQ: RIOT) Investments Solidify Effort to Build Decentralized Tech Platforms

Company’s investments in Verady, Coinsquare and TessPay among recent work to increase security for transactions Blockchain, cannabis sectors accounted for nearly 10 percent of rising daily activity for TD Ameritrade in 4Q2017 Estimated $10 billion in cryptocurrency transacted each day Riot Blockchain, Inc. (NASDAQ: RIOT) is advancing its focus on the rising blockchain technology and its cryptocurrency applications, as exemplified by its November announcement of its strategic investment in Verady, LLC, a company that provides accounting, auditing and verification for blockchain-based assets such as cryptocurrencies (http://cnw.fm/lNMe5). The strategy paid off with news that Riot Blockchain’s stock surged from $7 in…

News and publishing service for CBD related companies

Contact us: 303.498.7722